United States · Venture startup
8 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$120Mraised across 8 rounds since 2005, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $392K sold, first sale Nov 2013
No investor was named in the report.
From a historical funding recordSEC filing: $7.5M sold, first sale Jan 2014
Reported by finsmes.comSEC filing: $18M sold, first sale Jan 2010
No investor was named in the report.
From a historical funding recordSEC filing: $13M sold, first sale May 2009
No investor was named in the report.
From a historical funding recordSEC filing: $2.6M sold, first sale Mar 2009
Washington Research Foundation
Richard King Mellon Foundation
Wexford Capital
Handshake VenturesFrom a historical funding record
Morgenthaler Ventures
Adams Street Partners
Lilly Ventures
Partners Healthcare Group
GenentechFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Morgenthaler VenturesAdams Street PartnersHealthCare VenturesSequel Venture PartnersWashington Research FoundationRichard King Mellon FoundationLilly VenturesWexford CapitalPartners Healthcare GroupGenentechMissing a round, or an investor who was in one? Tell us.
GlobeImmune's investors include Morgenthaler Ventures, Adams Street Partners, HealthCare Ventures, Sequel Venture Partners and Washington Research Foundation, and 11 more on record.
GlobeImmune has raised $120M across 8 rounds since 2005.
GlobeImmune's most recent round was a Venture of $392K in Mar 2014.
GlobeImmune's largest round on record is $41M (Series C), in Sept 2007.
GlobeImmune's first round on record, in Dec 2005, was backed by Morgenthaler Ventures, Adams Street Partners and HealthCare Ventures and 5 others.
GlobeImmune's latest named round is a Venture, in Mar 2014.
GlobeImmune is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·